BillionToOne
BillionToOne is a molecular diagnostics company developing innovative tests using its Quantitative Counting Templates (QCTs) technology. Their tests offer high-precision prenatal screening and oncology diagnostics, redefining possibilities in the field. They have achieved significant growth, reaching $125M ARR in under four years.
Buy Funded Startups lists
Funding Round: Series D
Funding Amount: $130M
Date: 21-Jun-2024
Investors: Premji Invest, Neuberger Berman, Adam Street Partners, Baillie Gifford, Hummingbird Ventures, Civilization Ventures, Libertus Capital, Fifty Years
Markets: Healthcare, Diagnostics, Oncology, Prenatal, Biotechnology, Genetics, Medical
HQ: Menlo Park, California, United States
Founded: 2016
Website: https://www.billiontoone.com/
LinkedIn: https://www.linkedin.com/company/billiontoone
Twitter: https://twitter.com/billiontooneinc
Facebook: https://www.facebook.com/billiontoone
Crunchbase: https://www.crunchbase.com/organization/billiontoone
Leave a Comment
Comments
No comments yet.